Aveanna Healthcare Holdings Inc. AVAH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score

56/100

2/7 Pass

SharesGrow Intrinsic Value

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Aveanna Healthcare Holdings Inc. (AVAH) trades at a trailing P/E of 6.0, forward P/E of 11.4. Trailing earnings yield is 16.81%, forward earnings yield 8.75%. PEG 1.31. Graham Number is $4.88.

Criteria proven by this page:

VALUE (100/100, Pass) — P/E is below market average (6.0); analyst target implies upside (+69.7%); earnings yield beats bond yields (16.81%).
PEG Ratio 1.31 — between 1.0–2.0 indicates moderate valuation relative to growth.
Trailing Earnings Yield 16.81% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Analyst consensus target $11.25 (+69.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 56/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

56/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

Proven by this page

FUTURE

52/100

Analyst consensus

→ Forecast

✗

PAST

25/100

→ Income

✗

HEALTH

17/100

Debt-to-Equity & liquidity

→ Health

MOAT

60/100

→ Income

✓

GROWTH

90/100

→ Income

INCOME

45/100

→ Income

Valuation Snapshot — AVAH

Valuation Multiples

P/E (TTM)6.0

Forward P/E11.4

PEG Ratio1.31

Forward PEG1.31

P/B Ratio6.89

P/S Ratio0.59

EV/EBITDA9.4

Per Share Data

EPS (TTM)$1.11

Forward EPS (Est.)$0.58

Book Value / Share$0.96

Revenue / Share$11.96

FCF / Share$0.62

Yields & Fair Value

Earnings Yield16.81%

Forward Earnings Yield8.75%

Dividend Yield0.00%

Graham Number$4.88

SharesGrow IV$1.35 (-79.6%)

Analyst Target$11.25 (+69.7%)

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2018	-45.9	0.00	6.27	1.72	-
2019	-29.2	-0.51	8.23	1.61	-
2020	-39.1	1.60	8.35	1.49	-
2022	-11.7	-0.11	2.14	0.81	-
2022	-0.2	0.00	-34.67	0.08	-
2023	-3.8	0.05	-3.99	0.27	-
2024	-82.2	0.89	-7.36	0.44	-
2026	7.3	0.00	8.46	0.68	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2018	$-0.26	$1.25B	$-47.15M	-3.8%
2019	$-0.41	$1.38B	$-76.52M	-5.5%
2020	$-0.31	$1.5B	$-57.05M	-3.8%
2021	$-0.63	$1.68B	$-117.04M	-7%
2022	$-3.57	$1.79B	$-662.03M	-37%
2023	$-0.71	$1.9B	$-134.52M	-7.1%
2024	$-0.06	$2.02B	$-10.93M	-0.5%
2025	$1.05	$2.43B	$225.03M	9.2%

Analyst Estimates

Year	EPS (Avg)	EPS Range	Revenue (Avg)	Revenue Range	Analysts
2026	$0.58	$0.56 – $0.62	$2.42B	$2.4B – $2.46B	6
2027	$0.62	$0.59 – $0.65	$2.56B	$2.55B – $2.57B	5
2028	$0.69	$0.66 – $0.72	$2.7B	$2.69B – $2.71B	5
2029	$0.76	$0.75 – $0.77	$2.84B	$2.83B – $2.88B	2